NCT04704232View on ClinicalTrials.gov

Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 12, 2021

Primary Completion Date

March 10, 2021

Study Completion Date

March 10, 2021

Conditions

Pain

Interventions

DRUG

ACD440

Double blind, parallel within subject comparison

DRUG

PLAC

Double blind, parallel within subject comparison

Trial Locations (1)

Unknown

AlzeCure Pharma investigational site, Stockholm

Sponsors

Lead Sponsor

AlzeCure Pharma

All Listed Sponsors

lead

AlzeCure Pharma

INDUSTRY

NCT04704232 - Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers | Biotech Hunter | Biotech Hunter